Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04150900
Title 1922GCCC: Pembro and Bavituximab for Squamous Cell Carcinoma of Head and Neck
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Maryland, Baltimore
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Maryland Medical Center Baltimore Maryland 21201 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field